The National Dermatology Patient Pathways: should be used in association with drug recommendations and guidance in this section to inform the management of acne, alopecia, atopic eczema, benign skin lesions, generalised and local pruritus, hand and foot eczema, molluscum contagiosum, nail dystrophy, non-melanoma skin cancers, psoriasis, rosacea, scabies, solar (actinic) keratoses and Bowen’s Disease, suspicious pigmented lesions, urticaria, and viral warts. Also refer to the British Association of Dermatologists Clinical Guidelines at
For use of dermatologicals in children, refer to BNF for Children.

Read More